CNMD
CONMED Corporation
NYSEUSDEQUITY
DELAYED
Last price
51.07
▼ 0.31 (0.60%)
MARKET · —
Price
Open
51.38
Prev close
51.38
Day high
51.81
Day low
50.89
Volume
183.95K
Market cap
—
P/E (TTM)
—
52W range
31.44 – 56.64
Trailing performance
Returnvs SPY
1W
+1.31%
+2.7%
1M
+23.75%
+20.0%
3M
+37.95%
+34.9%
6M
+13.14%
+2.1%
YTD
+25.79%
+13.5%
1Y
-4.47%
-24.5%
3Y
-53.59%
-127.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
50.10
+1.94% from price
SMA 20
48.78
+4.69% from price
SMA 50
41.78
+22.25% from price
SMA 100
39.14
+30.48% from price
SMA 200
40.19
+27.08% from price
EMA 12
49.76
+2.63% from price
EMA 26
47.26
+8.06% from price
EMA 50
44.08
+15.87% from price
RSI (14)
66.0
Neutral
MACD (12,26,9)
2.50
Hist -0.20
ATR (14)
1.67
3.28% of price
Realised vol 30D
57.9%
Annualised
Bollinger upper
53.80
20, 2σ
Bollinger lower
43.76
20, 2σ
50 / 200 cross
Golden
41.78 vs 40.19
Trend bias
Above 200
+27.08%
Risk profile
Beta vs SPY
1.00
More volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
57.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-42.5%
Peak to trough
Max drawdown 5Y
-79.6%
Peak to trough
ATR 14
1.67
3.28% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio
Simply Wall St. · 4d ago
CONMED (CNMD) Shares Moved, What Is Behind The Fresh Attention?
Simply Wall St. · 4d ago
CNMD Jumps 16% in a Month as Investors Assess Whether It Can Last
Zacks · 5d ago
Is CNMD a Buy Now as Low Valuation Meets Persistent Execution Risk?
Zacks · 5d ago
Can CONMED's Raised 2026 EPS Outlook Reinforce Its Growth Momentum?
Zacks · 5d ago
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
Zacks · 5d ago
SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?
Zacks · 8d ago
Stocks making big moves this week: Huron, Sherwin-Williams, PROG, CONMED, and Freshworks
StockStory · 22d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.